Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Coca-Cola Femsa
KOF
$24.5B
| $9.91M | 0.02% |
128,503
+85,532
| +199% | +$7.13M |
|
1252
TriCo Bancshares
TCBK
$1.71B
| $9.91M | 0.02% |
243,192
+84,085
| +53% | +$3.03M |
|
|
ACH
1253
Accendra Health
ACH
$84.6M
| $9.88M | 0.02% |
338,209
+245,882
| +266% | +$7.26M |
|
|
MB
1254
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $9.87M | 0.02% |
381,708
+236,498
| +163% | +$5.86M |
|
1255
CALL
Walt Disney
DIS
$192B
| $9.86M | 0.02% |
100,000
-150,000
| -60% | -$15.4M |
|
|
1256
PUT
Walt Disney
DIS
$192B
| $9.86M | 0.02% |
+100,000
| New | +$10.3M |
|
1257
Arbor Realty Trust
ABR
$970M
| $9.85M | 0.02% |
1,200,947
+28,685
| +2% | +$234K |
|
|
UBNK
1258
DELISTED
United Financial Bancorp, Inc.
UBNK
| $9.84M | 0.02% |
538,025
+275,017
| +105% | +$4.78M |
|
1259
Globant
GLOB
$1.72B
| $9.82M | 0.02% |
245,176
+11,591
| +5% | +$478K |
|
|
GCP
1260
DELISTED
GCP Applied Technologies Inc.
GCP
| $9.82M | 0.02% |
319,733
-164,048
| -34% | -$4.91M |
|
|
DEA
1261
Easterly Government Properties
DEA
$1.19B
| $9.79M | 0.01% |
189,440
-61,844
| -25% | -$3.11M |
|
1262
Ionis Pharmaceuticals
IONS
$10.6B
| $9.79M | 0.01% |
193,043
+96,324
| +100% | +$5.05M |
|
|
NEOS
1263
DELISTED
Neos Therapeutics, Inc
NEOS
| $9.78M | 0.01% |
1,068,725
+475,447
| +80% | +$3.61M |
|
|
MRSH
1264
Marsh
MRSH
$92.8B
| $9.76M | 0.01% |
116,505
-402,832
| -78% | -$31.9M |
|
1265
Fabrinet
FN
$15.2B
| $9.74M | 0.01% |
262,955
+191,266
| +267% | +$7.83M |
|
1266
Danaher
DHR
$151B
| $9.7M | 0.01% |
127,506
-13,552
| -10% | -$1M |
|
|
ONDK
1267
DELISTED
On Deck Capital, Inc.
ONDK
| $9.69M | 0.01% |
2,073,892
+466,775
| +29% | +$2.16M |
|
|
MULE
1268
DELISTED
MuleSoft, Inc.
MULE
| $9.68M | 0.01% |
480,837
+448,277
| +1,377% | +$9.99M |
|
|
ALE
1269
DELISTED
Allete
ALE
| $9.66M | 0.01% |
125,013
+68,226
| +120% | +$5.11M |
|
1270
Innoviva
INVA
$1.52B
| $9.65M | 0.01% |
+683,771
| New | +$9.04M |
|
1271
Sally Beauty Holdings
SBH
$1.51B
| $9.65M | 0.01% |
493,037
+68,719
| +16% | +$1.35M |
|
|
BNCL
1272
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $9.64M | 0.01% |
580,959
+144,812
| +33% | +$2.21M |
|
1273
PUT
Morgan Stanley
MS
$339B
| $9.63M | 0.01% |
+200,000
| New | +$9.28M |
|
1274
NCR Voyix
VYX
$1.11B
| $9.63M | 0.01% |
418,463
-42,253
| -9% | -$972K |
|
|
AYR
1275
DELISTED
Aircastle Ltd
AYR
| $9.62M | 0.01% |
431,654
+279,137
| +183% | +$6.21M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.